Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving p210 bcr/abl-transduced bone marrow

Blood

Volumn 92, Issue 10, 1998, Pages 3780-3792

  Pear, Warren S ^a   Miller, Juli P ^b   Xu, Lanwei ^b   Pui, John C ^b   Soffer, Benny ^b   Quackenbush, Robert C ^b   Pendergast, Ann Marie ^b   Bronson, Roderick ^b   Aster, Jon C ^b   Scott, Martin L ^b   Baltimore, David ^b  

^a 1010 Vagelos Laboratories   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; DNA; GREEN FLUORESCENT PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS;

EID: 0032533257     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3780     Document Type: Article

References (48)

1. Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE: Hematology: Basic Principles and Practice (ed 2). New York, NY, Churchill Livingstone, 1995
2. Clarkson B, Strife A, Ferez A, Lambek C, Wisniewski D: Integration of molecular and biological abnormalities in quest for selective treatment of chronic myelogenous leukemia (CML). Leuk Lymphoma 11:81, 1993
3. Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132:1197, 1960
4. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G: Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93, 1984
5. McWhirter JR, Galasso DL, Wang JY: A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol Cell Biol 13:7587, 1993
6. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, Gishizky M: BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75:175, 1993
7. Goga A, McLaughlin J, Afar DE, Saffran DC, Witte ON: Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. Cell 82:981, 1995
8. Maru Y, Witte ON: The BCR gene encodes a novel serine/threonine kinase activity within a single exon. Cell 67:459, 1991
9. Melo JV: The molecular biology of chronic myeloid leukaemia. Leukemia 10:751, 1996
10. Jackson P, Baltimore D: N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J 8:449, 1989
11. Van Etten RA, Jackson PK, Baltimore D, Sanders MC, Matsudaira PT, Janmey PA: The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J Cell Biol 124:325, 1994
12. Kipreos ET, Wang JY: Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science 256:382, 1992
13. Konopka JB, Witte ON: Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol Cell Biol 5:3116, 1985
14. Heaney C, Kolibaba K, Bhat A, Oda T, Ohno S, Fanning S, Druker BJ: Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation. Blood 89:297, 1997
15. Salgia R, Brunkhorst B, Pisick E, Li JL, Lo SH, Chen LB, Griffin JD: Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCRyABL. Oncogene 11:1149, 1995
16. Tauchi T, Boswell HS, Leibowitz D, Broxmeyer HE: Coupling between p210bcr-abl and She and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway. J Exp Med 179:167, 1994
17. Yamanashi Y, Baltimore D: Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell 88:205, 1997
18. Carpino N, Wisniewski D, Strife A, Marshak D, Kobayashi R, Stillman B, Clarkson B: p62(dok): A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88:197, 1997
19. Cortez D, Kadlec L, Pendergast AM: Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol Cell Biol 15:5531, 1995
20. Oda T, Heaney C, Hagopian JR, Okuda K, Griffin JD, Druker BJ: Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. J Biol Chem 269:22925, 1994
21. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645, 1994
22. + cells. Blood 91:630, 1998
23. Hariharan IK, Harris AW, Crawford M, Abud H, Webb E, Cory S, Adams JM: A bcr-v-abl oncogene induces lymphomas in transgenic mice. Mol Cell Biol 9:2798, 1989
24. Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK, Groffen J: Acute leukemia in bcr/abl transgenic mice. Nature 344:251, 1990
25. Honda H, Fujii T, Takatoku M, Mano H, Witte ON, Yazaki Y, Hirai H: Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice. Blood 85:2853, 1995
26. Honda H, Oda H, Suzuki T, Takahashi T, Witte ON, Ozawa K, Ishikawa T, Yazaki Y, Hirai H: Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210(bcr/abl): A novel transgenic model for human Ph1-positive leukemias. Blood 91:2067, 1998
27. Daley GQ: Animal models of BCR/ABL-induced leukemias, Leuk Lymphoma 11:57, 1993 (suppl 1)
28. Daley GQ, Van Etten RA, Baltimore D: Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247:824, 1990
29. Kelliher MA, McLaughlin J, Witte ON, Rosenberg N: Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci USA 87:6649, 1990
30. Daley GQ, Van Etten RA, Baltimore D: Blast crisis in a murine model of chronic myelogenous leukemia. Proc Natl Acad Sci USA 88:11335, 1991
31. Elefanty AG, Cory S: Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions. Mol Cell Biol 12:1755, 1992
32. Gishizky ML, Johnson-White J, Witte ON: Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice. Proc Natl Acad Sci USA 90:3755, 1993
33. Hawley RG, Lieu FH, Fong AZ, Hawley TS: Versatile retroviral vectors for potential use in gene therapy. Gene Ther 1:136, 1994
34. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA: Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363:45, 1993
35. Pear WS, Aster JC, Scott ML, Hasserjian RP, Soffer B, Sklar J, Baltimore D: Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 183:2283, 1996
36. Kotani H, Newton PBr, Zhang S, Chiang YL, Otto E, Weaver L, Blaese RM, Anderson WF, McGarrity GJ: Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther 5:19, 1994
37. Pear WS, Cepko C: Transduction of genes using retrovirus vectors, in Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds): Current Protocols in Molecular Biology, Supplement 36. New York, NY, Wiley, 1996, p 9.9.1
38. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W: Current Protocols in Immunology. New York, NY, Wiley, 1992
39. Spangrude GJ: Biological and clinical aspects of hematopoietic stem cells. Annu Rev Med 45:93, 1994
40. Pear WS, Nolan GP, Scott ML, Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA90:8392, 1993
41. Bodine DM, Orlic D, Birkett NC, Seidel NE, Zsebo KM: Stem cell factor increases colony-forming unit-spleen number in vitro in synergy with interleukin-6, and in vivo in Sl/Sld mice as a single factor. Blood 79:913, 1992
42. Pawliuk R, Kay R, Lansdorp P, Humphries RK: Selection of retro virally transduced hematopoietic cells using CD24 as a marker of gene transfer. Blood 84:2868, 1994
43. Schott B, Iraj ES, Roninson IB: Effects of infection rate and selection pressure on gene expression from an internal promoter of a double gene retroviral vector. Somat Cell Mol Genet 22:291, 1996
44. Hestdal K, Ruscetti FW, Ihle JN, Jacobsen SE, Dubois CM, Kopp WC, Longo DL, Keller JR: Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol 147:22, 1991
45. Scott ML, Van Etten RA, Daley GQ, Baltimore D: v-abl causes hematopoietic disease distinct from that caused by bcr-abl. Proc Natl Acad Sci USA 88:6506, 1991
46. Hawley RG, Fong AZ, Ngan BY, de Lanux VM, Clark SC, Hawley TS: Progenitor cell hyperplasia with rare development of myeloid leukemia in interleukin 11 bone marrow chimeras. J Exp Med 178:1175, 1993
47. Zhang X, Ren R: Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: A novel model for chronic myelogenous leukemia. Blood 92:3829, 1998
48. Spangrude GJ, Brooks DM, Tumas DB: Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: In vivo expansion of stem cell phenotype but not function. Blood 85:1006, 1995